In the current study, oral lymphoma accounted for 1.1% of head and neck malignancies and 8%
of all lymphomas. Evidence shows that lymphomas comprise 1.5% to 8.8% of the oral
malignancies (
4-
6). The prevalence of oral lymphoma relative to all oropharyngeal
malignancies was reported to be 3.4% in a study by Razavi et al. (
6), in Isfahan, 8.8% in a study (
5), in Gilan, 65.5%. According to a study conducted in
Philadelphia, most cases of oral lymphomas were NHL and of B cell type with an estimated
prevalence rate of 41% to 100% (
7). In our
study, B cell lymphomas comprised 98% of the cases of oral lymphomas. In contrast, a study
in Japan reported a prevalence rate of 34% for B cell lymphoma and 28% for T cell lymphoma
(
8). An interesting point is that in
lymphomas of the nasal cavity and paranasal sinuses, although close to the oral cavity, the
prevalence of T cell lymphomas are very high and a previous study reported that 80% of the
lymphomas of the nasal cavity and paranasal sinuses were T cell lymphomas (
9). Another study conducted in Spain reported a
prevalence rate of 44% for T cell lymphomas in the afore-mentioned areas (
10). Thus, it may be concluded that B cell
lymphomas are more prevalent in the oral cavity while T cell lymphomas more commonly occur
in the nasal areas. In this study, the incidence of oral lymphoma was found to be 0.78 to
1.21 individuals per one million population from 2003 to 2008, respectively. The ascending
trend of lymphoma was also reported by Mousavi et al. (
5), in their study in 2009 on all lymphomas. The increased incidence may be due to
several factors. First of all, it may be due to the more recent diagnostic techniques in the
country enabling accurate diagnosis of lymphoma. Second of all, the new classification
systems suggested for lymphoma may include malignancies that were not classified as a
lymphoma previously. Thirdly, the quality of cancer registry has improved in the recent
years.
In general, lymphoma is the eighth most common cancer in men and the tenth most common
cancer in women. Although its incidence in less developed countries (4.2 in males, 2.8 in
females per 100,000) is far less than that in developed countries (10.3 in males and 7 in
females per 100,000), the morbidity and mortality due to this malignancy are much higher in
less developed countries (
11). In our study,
the incidence of oral lymphoma in men was 1.84 times that of women. The incidence of
lymphoma in Iran is 3.7 per 100,000 population in males and 2.3 per 100,000 population in
females (
5). In a study by Razavi et al. (
6), the frequency of oral lymphoma in men was 1.29
times that in women. In other communities, the male/female lymphoma incidence ratio varied
from 1/4 to 2/2 (
12,
13). In most previous studies, men were more commonly affected
than women. In contrast, in a study by Kemp et al. (
1), number of affected women was only slightly higher than men (53%).
Different classifications have been offered for staging of lymphoma. In the current study,
the most recent classification suggested by WHO for lymphoma was used. Most cases were NHL
(97.5%). HL and the composite form only comprised 1.8% and 0.7% of all cases, respectively.
Of the subgroup of NHLs, the type of lymphoma had not been specified in 21.7% of cases,
while 54.9% of cases were DLBL. The prevalence of SLL and FL was 12.4% and 4.6%,
respectively. Gnepp reported that DLBL was the most common type of lymphoma of Waldeyer’s
tonsillar ring followed by peripheral T cell lymphoma, MALT (mucosa-associated lymphoid
tissue) lymphoma and FL in a decreasing order of prevalence (
14) In our study, MALT and peripheral T cell lymphoma were each
seen in one case and follicular type was found in 20 cases. In a study by Mohtasham et al.
(
15), on 36 cases of oral lymphomas, DLBL
(41.1%), low-grade B cell lymphoma (35.2%), peripheral T cell lymphoma (11.7%), Burkitt’s
lymphoma (5.8%) and HL (5.8%) had the highest frequency in decreasing order. Although
Mohtasham et al. (
15) did not use the
accredited WHO classification for lymphomas, DLBL was the most common subtype, which is in
line with the results of the current study. In addition, Kemp et al. (
1) reported that DLBL comprised 58% and B cell lymphoma comprised
98% of cases. Moreover, Epstein et al. (
12), in
their study on 361 cases of oral lymphoma demonstrated a frequency of 38% for large B cell
lymphoma and 27.4% for small cell lymphoma. In their study, HL was only seen in 0.8% and
Burkitt’s lymphoma in 1.6% of cases; which is in accordance with our findings. In a study
(
3) MALT was the most frequent microscopic
subtype and DLBL ranked second, which is in contrast to our findings. This difference is
explained by the fact that they included lymphomas of the salivary glands in their
study.
In the current study, oral lymphoma had the highest frequency in the 4th to 8th decades of
life and the diagnosed cases were mostly in their 60s or 70s. In other studies, the mean age
of patients with oral lymphoma was 62.5 years and 71 years (
1,
12). In contrast,
Razavi et al. (
6), in their study in Iran
reported that more than half the cases of oral lymphomas had occurred in patients younger
than 40 years of age. Considering the large sample size of our study, the reported age range
in our study is more reliable than that of Razavi.
The tonsils are the most common site of occurrence of lymphoma in the oral cavity (77.8%).
This finding is in accord with the results of other studies (
12,
15,
16). Of 670 cases of oral lymphomas evaluated in a
study by DePe-a et al. (
17), one-third occurred
in the tonsils and one-third in other parts of Waldeyer’s tonsillar ring. Kolokotronis et al.
(
16), also reported the tonsils to be the
common site of involvement. In a study by Epstein et al. (
12) 53.7% of cases had occurred in Waldeyer’s tonsillar ring
(32.7% in the tonsils), 16.1% in the parotid gland and 13% in the pharynx. In a study by
Kemp et al. (
1), the maxilla and palate were the
most common sites of oral lymphomas, which may be due to the exclusion of tonsils from their
study. In a study by Etemad-Moghadam et al. (
2)
22% of cases had occurred in the tonsils, 15% in the parotid and 13% in the pharynx;
however, in our study only 1.6% of the lymphomas had occurred in the pharynx. This
difference is probably due to the fact that we only included lymphomas of the oropharynx in
our study, while in the above-mentioned study, lymphomas of the nasopharynx were also
included. Moreover, we only evaluated cases of lymphomas in the oral cavity and excluded the
major salivary glands, whereas another study (
3), in their study in Greece reported the most common site of involvement to be the
major salivary glands and Waldeyer’s ring ranked fourth. In our study, the base of the
tongue, which is included in Waldeyer’s ring, was the fourth, and the palate was the third
most common site of involvement, which is in line with the available literature.
Unfortunately, data earlier than 2003 were not available in the archives and those available
were not complete. Thus, the current study only evaluated a 6-year period. Approximately,
21.7% of lymphomas had been registered only as lymphoma with no specific information
regarding histopathological subtype. If their histological subtype had been registered, our
data would have been much more valuable. One limitation of the current study was
insufficient data regarding the clinical condition of patients and stage of cancer. No
information was available regarding the follow up of patients either; thus the survival rate
could not be calculated. Complete registry of information of cancer patients in national
registry systems can provide better data regarding the status of cancer in our country.
5.1. Conclusions
Oral lymphoma comprised 1.1% of all malignancies in the head and neck region and 8% of
all lymphomas in Iranian population. The age of onset, site of involvement, sex of
patients and histopathological subtype of oral lymphomas in Iran were similar to those of
most other countries.